CSIMarket
 
Celgene Corp  (CELG)
Other Ticker:  
 
 
 

Celgene Corp's vs. its Competitors Results

(List of Competitors, Financial Results for the last period ending MRQ, in Millions of $)



COMPANY NAME TICKER REVENUE NET INCOME NET MARGIN CASH FLOW
Celgene Corp 3 Q 2019 CELG 4,520.00 1,691.00 37.41 % 2,390.00
Merck and Co Inc 3 Q 2023 MRK 15,962.00 4,750.00 29.76 % 2,957.00
Abbvie inc 4 Q 2023 ABBV 14,301.00 824.00 5.76 % -473.00
Pfizer Inc 4 Q 2023 PFE 14,248.00 -3,360.00 - -316.00
Johnson and Johnson 4 Q 2023 JNJ 13,532.00 4,049.00 29.92 % 2,131.00
Bristol myers Squibb Company 4 Q 2023 BMY 11,477.00 1,762.00 15.35 % 3,951.00
Abbott Laboratories 4 Q 2023 ABT 10,241.00 1,594.00 15.56 % 187.00
Eli Lilly And Company 4 Q 2023 LLY 9,353.40 2,189.70 23.41 % 437.80
Amgen Inc 4 Q 2023 AMGN 8,196.00 767.00 9.36 % -23,797.00
Biogen Inc 4 Q 2023 BIIB 2,386.30 248.90 10.43 % -1,285.90
Alexion Pharmaceuticals Inc 1 Q 2021 ALXN 1,636.50 489.20 29.89 % 471.90
Enact Holdings Inc 4 Q 2023 ACT 296.19 157.31 53.11 % -62.31
APROX. MARKET 3 Q SUBTOTAL 106,149.39 15,162.11 14.28 % -15,798.51






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com